bioAffinity
  • Home
  • Publications
  • News
  • About Us
  • Videos
  • Contact
  • Investor Relations
Select Page

After going public, SA company making C-suite change, adding former Amazon executive

by Maria Zannes | May 8, 2023 | Articles, News

bioAffinity Technologies CEO Maria Zannes says the company has made a key hire May 4, 2023 As published in the San Antonio Business Journal By: W. Scott Bailey – Senior Reporter, San Antonio Business Journal BioAffinity Technologies Inc. has made a key change in its...

bioAffinity Technologies CEO Maria Zannes Shares CyPath®Lung with The Empowered Patient Podcast

by Maria Zannes | Mar 6, 2023 | Articles, News

MARCH 6, 2023 The Empowered Patient podcast host Karen Jagoda recently interviewed bioAffinity Technologies President and CEO Maria Zannes about the development of the CyPath® Lung test for the detection of early-stage lung cancer. Hear the podcast at...

“Fireside Chat” with Maria Zannes, CEO of bioAffinity Technologies, Inc. (NASDAQ: BIAF)

by Maria Zannes | Feb 22, 2023 | Articles, News

FEBRUARY 22, 2023 bioAffinity Technologies President and CEO Maria Zannes recently joined host Seth Farbman on his podcast From Start-Up to Stock Exchange. Listen here https://lnkd.in/g-vkTfKv to learn more about the need for early screening for lung cancer when it is...

Meet BioAffinity Technologies: Fly exclusive interview with CEO Maria Zannes

by Dale Harrison | Dec 28, 2022 | Articles, News

Meet BioAffinity Technologies: Fly exclusive interview with CEO Maria Zannes DECEMBER 28, 2022 As published in the The Fly By: Jessica de Sa-Mota BioAffinity focuses on the development of noninvasive, early-stage cancer diagnosis and targeted cancer treatment In an...

SA Cancer Diagnostic Company Adding Research Talent

by Dale Harrison | Dec 23, 2022 | Articles, News

SA Cancer Diagnostic Company Adding Research Talent DECEMBER 23, 2022 As published in the San Antonio Business Journal By: W. Scott Bailey – Senior Reporter, San Antonio Business Journal BioAffinity Technologies Inc. is making multiple personnel moves in an effort to...

Maria Zannes named to TEXAS 100 Influential professionals to watch in 2023

by Dale Harrison | Dec 21, 2022 | Articles, News

TEXAS 100 Influential professionals to watch in 2023 DECEMBER 21, 2022 As published in the San Antonio Business Journal By: Colin Pope – Editor, Austin Business Journal Our annual Texas 100 is a list of impactful Texans who will likely play crucial roles in the...
« Older Entries

Categories

  • Articles (18)
  • Events (37)
  • News (43)
  • Press Releases (65)
  • Publications (16)

Recent Posts

  • bioAffinity Technologies Holds Annual Meeting of Stockholders June 6, 2023
  • bioAffinity Technologies Presents Research Findings at CYTO 2023 May 22, 2023
  • bioAffinity Technologies Reports First Quarter 2023 Financial Results May 15, 2023
  • After going public, SA company making C-suite change, adding former Amazon executive May 8, 2023
  • bioAffinity Technologies Names Michael Dougherty as Chief Financial Officer May 1, 2023

Learn About CyPath Lung

CyPath Lung Test

Main Menu

  • Home
  • Publications
  • News
  • About Us
  • Videos
  • Contact
  • Investor Relations
Copyright © 2023 bioAffinity Technologies, Inc.